Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 15 hours ago
RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC
about 15 hours ago
Rare disease biotech Oak Hill is headed to the Nasdaq through a...
MapLight shares sink on mixed phase 2 schizophrenia readout
about 19 hours ago
MapLight Therapeutics’ stock plummeted more than 60% this morning after the neuro...
Apnimed aspires for up to $160M IPO as sleep apnea pill launch nears
about 19 hours ago
Apnimed has detailed its plans for an initial public offering, with the...
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
about 19 hours ago
The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC...
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
about 20 hours ago
InnoCare Pharma announced Monday that its oral tyrosine kinase 2 (TYK2) inhibitor...
After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration
about 20 hours ago
After signing a deal worth up to $486 million with Italian biopharma...
Legend Biotech CEO abruptly steps down without permanent replacement
about 21 hours ago
In a sudden leadership shift, Legend Biotech announced that its CEO Ying...
Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases
about 23 hours ago
Labcorp is launching the Marker by Labcorp Genetic Health Panel, a new...
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
1 day ago
Argenx is spending $2.2 billion to absorb Forte Biosciences for its phase...
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates
1 day ago
AstraZeneca executives told Fierce they are “very confident” in the pharma’s in-house...
Amgen sheds around 40 staffers amid continuing struggles
4 days ago
Amgen has laid off around 40 employees as part of “organizational changes”...
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
4 days ago
A new analysis of patients who took part in clinical trials for...